CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 3 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)»Hemolytic anemias (D55-D59)»Acquired hemolytic anemia (D59)

D59

Acquired hemolytic anemia

Sub-codes (9)

  • D59.0 Drug-induced autoimmune hemolytic anemia
  • D59.1 Other autoimmune hemolytic anemias

    2 indications for 93 drugs

  • D59.2 Drug-induced nonautoimmune hemolytic anemia
  • D59.3 Hemolytic-uremic syndrome

    1 indication for 7 drugs

  • D59.4 Other nonautoimmune hemolytic anemias
  • D59.5 Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
  • D59.6 Hemoglobinuria due to hemolysis from other external causes
  • D59.8 Other acquired hemolytic anemias
  • D59.9 Acquired hemolytic anemia, unspecified

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.